BRONCHOSTOP DUO chewing gum KWIZDA PHARMA GMBH
Active substance: thyme + mallow
R05CA10 Respiratory system | Expectorants, excl. combinations with cough suppressants
Indicated for: cough; pharyngeal irritation
Find medicines for human use by name or active substance.
Browse by initial
701–720 of 789 medicines
Active substance: thyme + mallow
R05CA10 Respiratory system | Expectorants, excl. combinations with cough suppressants
Indicated for: cough; pharyngeal irritation
Active substance: thyme + mallow
R05CA10 Respiratory system | Expectorants, excl. combinations with cough suppressants
Indicated for: cough; pharyngeal irritation
Active substance: mallow + linden + plantain
Indicated for: productive cough; expectoration
Active substance: miscellaneous
J07XN05 Antiinfectives for systemic use | Other vaccines
Indicated for: various therapeutic indications
Active substance: bromhexine
R05CB02 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: bromhexine
R05CB02 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: metformin
A10BA02 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Biguanides
Indicated for: type 2 diabetes mellitus
Active substance: metformin
A10BA02 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Biguanides
Indicated for: type 2 diabetes mellitus
Active substance: metformin
A10BA02 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Biguanides
Indicated for: type 2 diabetes mellitus
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ambroxol
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: ibuprofen
Indicated for: pain and inflammation
Active substance: ibuprofen
Indicated for: pain and inflammation
Active substance: ibuprofen
Indicated for: pain and inflammation
Active substance: ibuprofen
Indicated for: pain and inflammation
Active substance: ibuprofen + codeine
N02AJ08 Nervous system | Opioids | Opioids in combination with non-opioid analgesics
Indicated for: pain and inflammation
Active substance: zanubrutinib
Indicated for: hematologic malignancies
Active substance: zanubrutinib
Indicated for: hematologic malignancies
Active substance: tobramycin
J01GB01 Antiinfectives for systemic use | Aminoglycoside antibacterials | Other aminoglycosides
Indicated for: bacterial infections
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.